Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. [electronic resource]
Producer: 20060613Description: 992-1001.e6 p. digitalISSN:- 1549-4713
- Aged
- Aged, 80 and over
- Aptamers, Nucleotide -- adverse effects
- Choroidal Neovascularization -- drug therapy
- Double-Blind Method
- Female
- Fluorescein Angiography
- Humans
- Injections
- Intraocular Pressure -- drug effects
- Macular Degeneration -- complications
- Male
- Middle Aged
- Prospective Studies
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- drug effects
- Vitreous Body
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.